Related Experiment Video
Updated: Jun 12, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
Critical role for transcriptional repressor Snail2 in transformation by oncogenic RAS in colorectal carcinoma cells
1Signal Transduction Laboratory, Cancer Research UK London Research Institute, London, UK.
Abstract:
Activating mutations in the KRAS gene are among the most prevalent genetic changes in human cancers. To identify synthetic lethal interactions in cancer cells harbouring mutant KRAS, we performed a large-scale screen in isogenic paired colon cancer cell lines that differ by a single allele of mutant KRAS using an inducible short hairpin RNA interference library. Snail2, a zinc finger transcriptional repressor encoded by the SNAI2 gene, was found to be selectively required for the long-term survival of cancer cells with mutant KRAS that have undergone epithelial-mesenchymal transition (EMT), a transdifferentiation event that is frequently seen in advanced tumours and is promoted by RAS activation. Snail2 expression is regulated by the RAS pathway and is required for EMT. Our findings support Snail2 as a possible target for the treatment of the broad spectrum of human cancers of epithelial origin with mutant RAS that have undergone EMT and are characterized by a high degree of chemoresistance and radioresistance.
Insights
Activating KRAS mutations drive cancer. Researchers found Snail2 is essential for survival in KRAS-mutant cancer cells that underwent epithelial-mesenchymal transition (EMT), suggesting Snail2 as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Activating mutations in the KRAS gene are common in human cancers.
- Epithelial-mesenchymal transition (EMT) is a process frequently observed in advanced tumors and is promoted by RAS pathway activation.
Purpose of the Study:
- To identify synthetic lethal interactions in cancer cells with mutant KRAS.
- To investigate the role of Snail2 in KRAS-mutant cancer survival and EMT.
Main Methods:
- Conducted a large-scale screen using an inducible short hairpin RNA interference library.
- Utilized isogenic paired colon cancer cell lines differing by a single allele of mutant KRAS.
Main Results:
- Identified Snail2 (encoded by SNAI2 gene) as selectively required for long-term survival of KRAS-mutant cancer cells that underwent EMT.
- Demonstrated that Snail2 expression is regulated by the RAS pathway and is essential for EMT.
Conclusions:
- Snail2 is crucial for the survival of KRAS-mutant cancers with EMT.
- Snail2 represents a potential therapeutic target for epithelial cancers with mutant RAS, EMT, chemoresistance, and radioresistance.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Co-activators and Co-repressors
Abnormal Proliferation
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Master Transcription Regulators
